Print ISSN: 2581-9356
Online ISSN: 2581-9364
CODEN : IIJOCV
IP Indian Journal of Orthodontics and Dentofacial Research (IJODR) open access, peer-reviewed quarterly journal publishing since 2015 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the more...Review Article
Author Details :
Volume : 5, Issue : 4, Year : 2019
Article Page : 126-129
https://doi.org/10.18231/j.ijodr.2019.027
Abstract
The aim of the review article is to analyze the current information regarding the role of pharmaceutical products which might have an impact on the rate of tooth movement that can be accomplished orthodontically. The biochemical pathway for orthodontic movement of a tooth or teeth is found to be accelerated by the tooth movement arising at the level of cells and molecules.
Many medications consumed by patients may have an adverse effect either by increasing or decreasing the movement of teeth orthodontically, so the clinician should be aware of such drugs along with the favourable and unfavourable effects on humans. This article extensively describes about the numerous possible medications that may cause changes in the maximum orthodontical movement of tooth.
Keywords: Bone and PDL, Tooth movement, Promotor agents, Suppressor agents.
How to cite : Payyapilly D J, Joseph L S, Skaria J , B.r A, Hassan H , Drug therapy in orthodontics – A review. IP Indian J Orthod Dentofacial Res 2019;5(4):126-129
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.